Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyCyclophosphamideStem CellsTreatment OutcomeAntineoplastic AgentsHematopoietic Stem Cell MobilizationHematopoietic Stem CellsChemotherapy, AdjuvantLymphoma, Non-HodgkinGranulocyte Colony-Stimulating FactorStem Cell TransplantationLeukapheresisSalvage TherapyCord Blood Stem Cell TransplantationTransplantation, HomologousAntigens, CD34Blood Component RemovalEmbryonic Stem CellsTransplantation ConditioningAdult Stem CellsMelphalanHematologic NeoplasmsDose-Response Relationship, DrugGraft vs Host DiseaseBone Marrow TransplantationPluripotent Stem CellsEtoposideGraft SurvivalStem Cell NicheMultiple MyelomaDoxorubicinCell DifferentiationAntineoplastic Agents, AlkylatingDisease-Free SurvivalNeural Stem CellsBusulfanInduced Pluripotent Stem CellsBlood CellsHematopoiesisCisplatinStem Cell FactorBlood Cell CountSurvival RateThiotepaSurvival AnalysisRecurrenceTime FactorsFetal BloodMultipotent Stem CellsMesenchymal Stem Cell TransplantationIfosfamideNeoplasmsCytarabineMesenchymal Stromal CellsBreast NeoplasmsDrug Administration ScheduleCell LineageTissue DonorsWhole-Body IrradiationMyeloablative AgonistsCarboplatinRemission InductionBone Marrow CellsHodgkin DiseaseMethotrexateLeukemiaColony-Forming Units AssayTransplantation ChimeraPrognosisCells, CulturedHistocompatibilityCell SeparationFollow-Up StudiesBone MarrowInfectionLeukemia, Myeloid, AcuteFlow CytometryRecombinant ProteinsLymphomaPlatelet CountVidarabineStem Cell ResearchHematologic DiseasesCell ProliferationHistocompatibility TestingNeutropeniaBone Marrow PurgingNeoplasm StagingPlant StemsProspective StudiesFetal Stem CellsBlood DonorsFeasibility StudiesNeoadjuvant TherapyImmunomagnetic SeparationPaclitaxel